{
    "title": "Valuing Pharmaceutical Drug Innovations. (arXiv:2212.07384v2 [econ.GN] UPDATED)",
    "abstract": "We measure the $\\textit{value of pharmaceutical drug innovations}$ by estimating the market values of drugs and their development costs. We rely on market responses to drug development announcements to identify the values and costs. Using data on announcements by firms and their daily stock returns, we estimate the average value of successful drugs at \\$1.62 billion. At the discovery stage, on average, drugs are valued at \\$64.3 million and cost \\$58.5 million. The average costs of the three phases of clinical trials are \\$0.6, \\$30, and \\$41 million, respectively. We also investigate applying these estimates to policies supporting drug development.",
    "link": "http://arxiv.org/abs/2212.07384",
    "context": "Title: Valuing Pharmaceutical Drug Innovations. (arXiv:2212.07384v2 [econ.GN] UPDATED)\nAbstract: We measure the $\\textit{value of pharmaceutical drug innovations}$ by estimating the market values of drugs and their development costs. We rely on market responses to drug development announcements to identify the values and costs. Using data on announcements by firms and their daily stock returns, we estimate the average value of successful drugs at \\$1.62 billion. At the discovery stage, on average, drugs are valued at \\$64.3 million and cost \\$58.5 million. The average costs of the three phases of clinical trials are \\$0.6, \\$30, and \\$41 million, respectively. We also investigate applying these estimates to policies supporting drug development.",
    "path": "papers/22/12/2212.07384.json",
    "total_tokens": 777,
    "translated_title": "评估制药药品创新价值",
    "translated_abstract": "我们通过估计药品市场价值和研发成本来衡量制药药品创新的价值。我们依靠市场对药品研发公告的反应来确定价值和成本。利用公司公告数据和日收益率，我们估计成功药品的平均价值为16.2亿美元。平均而言，发现阶段的药品评估为6430万美元，成本为5850万美元。三个临床试验阶段的平均成本分别为600万美元、3000万美元和4100万美元。我们还研究了将这些估计应用于支持药品研发的政策的可能性。",
    "tldr": "通过市场价值和研发成本，估计了制药药品创新的平均价值。成功药品的平均价值为 16.2 亿美元，临床试验前阶段的平均价值为 6430 万美元，成本为 5850 万美元。",
    "en_tdlr": "The study measures the value of pharmaceutical drug innovations by estimating market values and development costs. Successful drugs are valued at an average of 1.62 billion dollars, while drugs in the discovery stage have an average value of 64.3 million dollars and cost 58.5 million dollars. The study also investigates the potential applications of these estimates in policies supporting drug development."
}